The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of pazopanib in patients with von Hippel-Lindau disease.
 
Eric Jonasch
Consulting or Advisory Role - Cerulean Pharma; Eisai; Exelixis; Genentech/Roche; Novartis; Pfizer
Research Funding - Exelixis; Novartis; Onyx; Pfizer
Travel, Accommodations, Expenses - Cerulean Pharma; Novartis; Pfizer
 
Dan S. Gombos
No Relationships to Disclose
 
Steven G. Waguespack
No Relationships to Disclose
 
Valerie Marcott
No Relationships to Disclose
 
Diane D Liu
No Relationships to Disclose
 
Justin Alexander Weldon
No Relationships to Disclose
 
Shelly Bird
No Relationships to Disclose
 
Christine Robichaux
No Relationships to Disclose
 
Nizar M. Tannir
Honoraria - Argos Therapeutics; Bristol-Myers Squibb; Calithera Biosciences; Exelixis; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Argos Therapeutics; Bristol-Myers Squibb; Calithera Biosciences; Exelixis; Nektar; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Epizyme; Exelixis; Mirati Therapeutics; Novartis
Travel, Accommodations, Expenses - Argos Therapeutics; Argos Therapeutics; Bristol-Myers Squibb; Calithera Biosciences; Exelixis; Nektar; Novartis; Pfizer
 
Ashley Henriksen Woodson
No Relationships to Disclose
 
Greg Fuller
No Relationships to Disclose
 
Ian E. McCutcheon
No Relationships to Disclose
 
Surena F. Matin
Consulting or Advisory Role - Theracoat; Urogen pharma
Research Funding - AT&T